Hence screw dislocations in AlN are established as highly prominent conductive nanowires in semiconducting thin films and prospects for novel, highly functional nano-device materials through exploitation of screw TDs are attested. (C) 2011 American Institute of Physics. [doi:10.1063/1.3632985]“
“Background: Many of the foods abundant HM781-36B in vivo in the traditional Mediterranean diet, such as vegetables and fish, have been associated with slower cognitive
Objective: We investigated whether adherence to a Mediterranean dietary pattern or to the Healthy Eating Index-2005 (HEI-2005) is associated with cognitive change in older adults.
Design: This article is based on analyses of data from an ongoing longitudinal study in adults aged >= 65 y known as the Chicago Health and Aging Project (CHAP). CHAP participants (2280 blacks and 1510 whites) with >= 2 cognitive assessments were evaluated for adherence to 1) the Mediterranean dietary pattern (MedDiet; maximum score: 55) and 2) the HEI-2005 (maximum score: 100). For both scoring systems, higher scores connote greater adherence. Cognitive function was assessed at 3-y intervals on the basis of a composite measure of global cognition. Linear mixed models were used to examine
the association of dietary scores to change in cognitive function. Mean follow-up RG7112 time was 7.6 y.
Results: Mean (+/- SD) scores for participants were 28.2 +/- 0.1 for the MedDiet and 61.2 +/- 9.6 for the HEI-2005.
White participants had higher energy-adjusted MedDiet scores but lower HEI-2005 scores than did black participants. Higher MedDiet scores were associated with slower rates of cognitive decline (beta = +0.0014 per 1-point increase, SEE = 0.0004, P = 0.0004) after adjustment for age, sex, race, education, participation in cognitive activities, and energy. No such associations were observed for HEI-2005 scores.
Conclusion: The Mediterranean dietary pattern as captured by the MedDiet scoring system may reduce the rate of cognitive decline with older age. Am J Clin Nutr 2011;93:601-7.”
“Exposure of pregnant women and their unborn Navitoclax in vitro children to engineered nanoparticles (NPs) is not yet of major public concern. However, this may soon change in light of the ever-increasing production of NPs and the continuous appearance of novel NP-containing consumer products. However, NPs may not only pose risks to exposed individuals; they offer major potential for the development of novel therapeutic strategies to treat specifically either the mother or the developing foetus. Hence there is every reason to explore the transplacental transfer of engineered NPs in more detail, and to find answers to the vast number of open questions in this fascinating field of research.